Metraipolis › archive › dc_c95bfdacdc31

Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case… — Europe PMC PMID:42539885

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42539885
DOI
10.1093/skinhd/vzag072
License (as archived)
solo-consultazione
Archived
2026-10-19T06:21:39.890Z
SHA-256 of the archived text
5d00fcc1f9fbd9bf4fa9b4648787a7f5918bba8e2a94e1a02dae6bf25570b1c5
Stable URL of this page
https://metraipolis.com/documento/dc_c95bfdacdc31

How to cite

Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case… — Europe PMC PMID:42539885 — Europe PMC (en), https://europepmc.org/article/MED/42539885 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c95bfdacdc31 (Metraipolis archive dc_c95bfdacdc31, sha256 5d00fcc1f9fbd9bf4fa9b4648787a7f5918bba8e2a94e1a02dae6bf25570b1c5)
BibTeX
@misc{dcc95bfdacdc31,
  title = {Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case… — Europe PMC PMID:42539885},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42539885},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c95bfdacdc31; sha256 5d00fcc1f9fbd9bf4fa9b4648787a7f5918bba8e2a94e1a02dae6bf25570b1c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42539885. Agents can read the archived copy with the MCP tool read_document.